| |
|
Cardiomyopathy Treatment Program Home
Contact Us
Programs and Services
 Heart Failure
Cardiac Transplant
Ventricular Assist Device (VAD)
Pulmonary Hypertension
Treatment Options
Patients
Understanding Cardiomyopathy
Living with Cardiomyopathy
Patient and Visitor Information
Directions
Staff
Providers
Referring Physician Resources
Research
Success Stories
Support Us
Online Donation
Iowa Donor Network
In the News
UI Heart and Vascular Center
|
|
|
University of Iowa Heart and Vascular Care
Diagnosis and Treatment
Each pulmonary hypertension patient is evaluated on a case-by-case basis. Then, using the most advanced techniques and treatments available, members of the team design a treatment program to meet individual needs. Team members follow patients through both inpatient and outpatient settings to provide consistent, high quality care.
Diagnosis
Advanced diagnostic testing includes:
Treatment
Medications and treatments are prescribed and adjusted specific to levels of health and tolerance.
Individual treatment may include:
- Patient education
- Closely monitored outpatient follow-up by members of the multidisciplinary team
- Continuous IV (Prostacyclin)
- Epoprostenol (Flolan®)
- Treprostinil (RemodulinTM)
- Continuous SQ (Prostacyclin)
- Treprostinil (RemodulinTM)
- Inhaled Prostacyclin
- Oral Endothelin Receptor Antagonist
- Oral Phosphodiesterase Type 5 (PDE5) Inhibitor
- Oral Calcium Channel Blockade
- Conventional Medical Therapy
- Enrollment in FDA--sponsored medication clinical trials
|
|
|
